A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date10/25/189/24/20

Funding

  • Pharmaceutical Research Associates: $12,604.00